Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Ruxience 500 mg concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
rituximab
Company:  
Pfizer Limited See contact details
ATC code: 
L01FA01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Ruxience Healthcare professional guide

{healthcare_pro_orange} For Healthcare Professionals
Provides guidance on the route of administration (intravenous only), management, monitoring and safety considerations related to the risk management plan.
{pdf_link}

Ruxience Patient Alert Card

Provides help to patients to understand the risks associated with Ruxience and reminds them to seek immediate medical attention if they experience any of the listed signs and symptoms.
{pdf_link}

Ruxience Patient Brochure

Provides information to patients on the risks, signs and symptoms of infection and the need to contact their doctor immediately if they experience them.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Pfizer Limited
Company image
Address
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone
+44 (0)1304 616 161
Medical Information Website
www.pfizermedicalinformation.co.uk
Medical Information Direct Line
+44 (0)1304 616161